MEDSERV BIOTECH CO., LTD.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
MEDSERV BIOTECH CO., LTD. provides a wide range of testing services, including trauma, spine, joint, bone materials, packaging materials, sterility, and dental testing, assisting customers with comprehensive services from medical product development to obtaining marketing clearance. These services cover various medical devices, including bone plates, bone screws, bone pins, bone wires, intramedullary nails, external fixators, spinal fixation systems, interbody fusion cages, dental implants, orthodontic screws, electrosurgical knives, packaging materials, assistive devices, dressings, and craniofacial bone screws and plates.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2016
Unified Business No.
24921054
Status
Active
Number of Employees
10
Total Paid-in
Capital
10,000,000 (NT$)
Location of Company
Taiwan
, Tainan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Our mission is to provide the expertise and testing solutions you need to validate designs, meet regulatory standards, ensure reliable performance, and bring your products to market on time and within budget.
Established in 2016, Chang Yin Technology (MedServ) provides services covering international medical device research and development, manufacturing, testing, and regulatory certification, achieving one-stop integration across the product life cycle. We assist domestic and international medical industries with manufacturing (ISO 13485) and marketing clearance applications, and actively collaborate with medical centers, corporate foundations, academic institutions, and other entities. We offer professional service capabilities in physical properties, packaging materials, sterilization, biocompatibility, chemical properties, electromagnetic compatibility, safety regulations, and environmental reliability, ushering in a brand-new era for smart medical factories. Furthermore, the company continuously promotes production technology guidance for medical manufacturers to produce green medical devices, cooperates with medical institutions to implement low-carbon healthcare, and formulates smart carbon reduction strategies, aiming to achieve the goal of sustainable development and net-zero emissions across the upstream and downstream of the medical industry.
(The content above was translated by AI.)
Established in 2016, Chang Yin Technology (MedServ) provides services covering international medical device research and development, manufacturing, testing, and regulatory certification, achieving one-stop integration across the product life cycle. We assist domestic and international medical industries with manufacturing (ISO 13485) and marketing clearance applications, and actively collaborate with medical centers, corporate foundations, academic institutions, and other entities. We offer professional service capabilities in physical properties, packaging materials, sterilization, biocompatibility, chemical properties, electromagnetic compatibility, safety regulations, and environmental reliability, ushering in a brand-new era for smart medical factories. Furthermore, the company continuously promotes production technology guidance for medical manufacturers to produce green medical devices, cooperates with medical institutions to implement low-carbon healthcare, and formulates smart carbon reduction strategies, aiming to achieve the goal of sustainable development and net-zero emissions across the upstream and downstream of the medical industry.
(The content above was translated by AI.)
